Be a part of 13^th International Conference on Gynecology and Obstetrics

Session1: Advances in Reproductive Medicine
This session focuses on the cutting-edge developments in reproductive medicine, particularly in assisted reproductive technologies (ART). Topics may include the latest in vitro fertilization (IVF) techniques, such as preimplantation genetic testing (PGT), time-lapse imaging of embryos, and the use of artificial intelligence in embryo selection. Additionally, the session could cover innovations in ovarian stimulation protocols, the role of personalized medicine in fertility treatments, and emerging technologies like mitochondrial replacement therapy.
American College of Obstetricians and Gynecologists (ACOG) | Royal College of Obstetricians and Gynaecologists (RCOG) | International Federation of Gynecology and Obstetrics (FIGO) | Society of Maternal-Fetal Medicine (SMFM) | Society of Obstetricians and Gynaecologists of Canada (SOGC)

Session2: Abortion and Complications
Abortion is a medical procedure to end a pregnancy, either through medication or surgery. While generally safe, it can lead to complications such as infection, excessive bleeding, or incomplete abortion, where some tissue remains in the uterus. Other risks include uterine perforation or cervical injury. Women who choose to stop their pregnancies deal with problems like a high chance of infertility, increased chance of STDs, breast cancer, and other health problems. Sometimes, removing a foetus without doctor permission ends in death and a number of complications.
European Society of Human Reproduction and Embryology (ESHRE) | American Society for Reproductive Medicine (ASRM) | Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) |  Asian Oceania Federation of Obstetrics and Gynaecology (AOFOG) | Canadian Society of Obstetricians and Gynaecologists (SOGC) | Columbia University (Vagelos College of Physicians and Surgeons) 

Session3: Gynecologic Oncology: Innovations in Diagnosis and Treatment
This session focuses on the latest advancements in the diagnosis and treatment of gynaecologic cancers, including ovarian, cervical, uterine, and vulvar cancers. The discussion may include the development of targeted therapies, such as PARP inhibitors for ovarian cancer, and the role of immunotherapy in treating gynecologic malignancies. Advances in minimally invasive surgical techniques, like robotic-assisted surgery, and their impact on patient outcomes could be explored.
American Urological Association (AUA) | American Association of Clinical Endocrinologists (AACE) | Endocrine Society | Society of Obstetric Anesthesia and Perinatology (SOAP) | International Society for the Study of Women's Sexual Health (ISSWSH)

Session4: Contraception and Family Planning
This session covers the latest developments in contraceptive methods and family planning strategies. Topics might include new formulations of hormonal contraceptives, such as extended-cycle pills, patches, and rings, as well as non-hormonal options like copper IUDs. The session could explore advancements in long-acting reversible contraceptives (LARCs), including subdermal implants and hormonal IUDs, and their role in reducing unintended pregnancies. Innovations in male contraception, emergency contraception, and permanent sterilization techniques may also be discussed.
European Society of Gynaecological Oncology (ESGO) | American Association for Cancer Research (AACR) | World Federation of Associations of Pediatric Surgeons (WOFAPS)  | Harvard University | Johns Hopkins University | Stanford University | University of Oxford

Session5: Endometriosis
Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus, often on the ovaries, fallopian tubes, or pelvic organs. This causes chronic pain, especially during menstruation, and can lead to heavy bleeding, pain during intercourse, and infertility. The exact cause is unclear, but factors such as genetics, immune system disorders, and hormonal imbalances may play a role. Diagnosis typically involves pelvic exams, imaging, and sometimes Laparoscopy. Treatment options include pain relief medications, hormonal therapies, and surgical removal of endometrial tissue. Early diagnosis and management are crucial for improving symptoms and quality of life.
University of Cambridge | University of Toronto | University of Pennsylvania | University of Melbourne | University of California |  San Francisco (UCSF)

Session6: Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder in women, typically emerging during reproductive years. It is characterized by the formation of multiple small, fluid-filled sacs or cysts on the ovaries, leading to disrupted menstrual cycles and elevated levels of male hormones (androgens). Symptoms can vary but often include irregular periods, acne, excessive hair growth, and difficulty in conceiving. The exact cause of PCOS is still unclear, though it is often associated with insulin resistance and genetic factors. Effective management includes a combination of lifestyle changes, such as diet and exercise, and medical interventions to address symptoms and improve fertility.
University of Michigan | Northwestern University (Feinberg School of Medicine) | McGill University | University of British Columbia | University of Montreal | McMaster University | University of São Paulo | National Autonomous University of Mexico

Session7: Minimally Invasive Gynecologic Surgery
This session explores the role of minimally invasive surgical techniques in the treatment of gynecological conditions, such as endometriosis, Fibroids, and pelvic organ prolapse. Topics may include the latest advancements in laparoscopic and hysteroscopic surgeries, as well as the increasing use of robotic-assisted surgery for complex cases. The session could discuss the benefits of these techniques, including reduced recovery times, lower complication rates, and improved cosmetic outcomes, as well as the challenges, such as the steep learning curve and the cost of robotic systems.
Mayo Clinic | Cleveland Clinic | Johns Hopkins Hospital  | Massachusetts General Hospital (MGH) | Brigham and Women’s Hospital | Charité – Universitätsmedizin Berlin | Singapore General Hospital (SGH) | St. Thomas' Hospital | Karolinska University Hospital

Session8: Female Infertility & IVF Treatment
The woman's window for conception is now closed. The biggest factor affecting a woman's fertility and chances of getting pregnant and having a child is her age. Some of the most well-known causes of infertility in women include endometriosis, polycystic ovarian syndrome (PCOS), tubal obstruction, and advanced maternal age, which reduces egg quantity and quality.
In vitro fertilisation is a type of supported reproductive technology used to treat gravidity. In IVF, sperm and an egg are fertilised in a liquid media outside of the body.
The Royal Women’s Hospital | University College Hospital (UCH) | Mount Sinai Hospital | King’s College Hospital | National University Hospital (NUH)  | Guy's and St Thomas' NHS Foundation Trust | Tokyo Women's Medical University Hospital | Hospital of the University of Pennsylvania (HUP)

Session9: Sexually Transmitted Diseases
The contagious etiologies of cervicitis, which are all Sexually Transmitted Infections (STIs), are essentially more typical than the noncontagious causes. Since the female genital tract is adjoining from the vulva to the fallopian tubes, there is some cover among vulvovaginitis and cervicitis; the two conditions are usually sorted as lower genital tract contaminations.
Beth Israel Deaconess Medical Center | King Edward Memorial Hospital | Queen Charlotte's and Chelsea Hospital | Hospital Clínic de Barcelona  | Sheba Medical Center | Aarhus University Hospital | Peking Union Medical College Hospital | Royal Prince Alfred Hospital

Session10: Menopause and Hormone Replacement Therapy
This session focuses on the latest research and clinical practices related to menopause management, with a particular emphasis on Hormone Replacement Therapy (HRT). Topics may include the benefits and risks of HRT, the impact of different formulations and delivery methods (e.g., oral, transdermal, and vaginal), and the timing of initiation relative to menopause onset. The session could also cover non-hormonal alternatives for managing menopausal symptoms, such as selective serotonin reuptake inhibitors (SSRIs), gabapentin, and phytoestrogens.
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital | Beijing Obstetrics and Gynecology Hospital, Cincinnati Children's Hospital Medical Center | Pontifical Catholic University of Chile | University of Buenos Aires | Federal University of Rio de Janeiro

Session11: Obstetric Emergencies: Preparedness and Response
This session examines best practices for managing obstetric emergencies, which are critical to improving maternal and neonatal outcomes. Topics may include the recognition and management of life-threatening conditions such as Postpartum Hemorrhage, eclampsia, uterine rupture, and shoulder dystocia. The session could discuss the importance of rapid response teams, simulation training, and standardized protocols in improving the management of obstetric emergencies. Additionally, the session might cover the role of point-of-care ultrasound, blood transfusion protocols, and the use of uterotonics in preventing and treating postpartum hemorrhage.
Lausanne University Hospital | San Raffaele Hospital  | University of Milan | Sapienza University of Rome | University of Bologna | University of Padua | University of Turin | University of Florence | University of Naples Federico II | University of Rome Tor Vergata

Session12: Mental Health in Obstetrics and Gynecology
This session highlights the importance of addressing mental health issues in women, particularly during pregnancy and the postpartum period. Topics may include the identification and management of perinatal mood and anxiety disorders, such as postpartum depression, anxiety, and psychosis. The session could explore the impact of mental health on pregnancy outcomes, including the effects of untreated depression on fetal development and the risks associated with the use of psychotropic medications during pregnancy.
Catholic University of the Sacred Heart | Imperial College London | University College London (UCL) | King’s College London  | Charité – Universitätsmedizin Berlin | Ludwig Maximilian University of Munich  | Center for Reproductive Medicine at Cleveland Clinic 

Session13: Technological Innovations in Obstetric Imaging
This session reviews the latest advancements in obstetric imaging technologies, which play a crucial role in prenatal diagnosis and the management of pregnancy complications. Topics may include the use of 3D and 4D ultrasound in assessing fetal anatomy and detecting congenital anomalies, as well as the role of Doppler ultrasound in monitoring fetal well-being and placental function. The session could explore the applications of magnetic resonance imaging (MRI) in obstetrics, particularly in complex cases like placental accreta spectrum disorders and fetal brain abnormalities.
Magee-Womens Research Institute | Center for Women's Health Research at University of North Carolina | Columbia University Irving Medical Center - Department of Obstetrics and Gynecology | Massachusetts General Hospital (MGH) - Vincent Center for Reproductive Biology | Stanford University - Department of Obstetrics and Gynecology 

Session14: Abnormal Uterine Bleeding
Abnormal uterine bleeding (AUB) is a condition where menstrual bleeding is irregular, excessively heavy, or prolonged, disrupting normal cycles. It can occur due to various causes, including hormonal imbalances, structural abnormalities like fibroids or polyps, and systemic conditions such as clotting disorders. AUB may also be a sign of more serious issues like endometrial cancer. Women experiencing AUB often face challenges like anemia, fatigue, and reduced quality of life. Diagnosis typically involves a detailed medical evaluation, including blood tests, imaging, and sometimes a biopsy.
Johns Hopkins Medicine - Department of Gynecology and Obstetrics |  San Francisco (UCSF) - Bixby Center for Global Reproductive Health | Lunenfeld-Tanenbaum Research Institute (LTRI) at Mount Sinai Hospital | McGill University Health Centre - Research Institute | BC Women’s Hospital + Health Centre - Women’s Health Research Institute

Session15: Women Health and Nursing
Ladies have special wellbeing related issue. Novel heath issues incorporate pregnancy, menopause, and states of the female organs. Ladies can have a sound pregnancy by getting appropriate, early and ordinary pre-birth care. They are additionally prescribed a few tests for cervical cancer, breast disease and bone thickness screenings. Complexities of pregnancy incorporate medical issues that happen amid pregnancy. They can include child's wellbeing, mother's wellbeing or both.
Nuffield Department of Women's & Reproductive Health at the University of Oxford | MRC Centre for Reproductive Health at the University of Edinburgh  | Tommy’s National Centre for Miscarriage Research  | Institut Curie | Amsterdam UMC - Women’s Health Research

Gynecology and Obstetrics Market Size

The global gynecology and obstetrics market encompasses a wide range of products, services, and technologies related to women's reproductive health. This sector is driven by several key factors, including increasing awareness of women's health issues, technological advancements, the aging population, and rising demand for minimally invasive procedures. The global gynecology devices market was valued at approximately USD 11 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of around 7% from 2024-2030.

Market Challenges: -

• Regulatory Hurdles: Stringent regulatory requirements for medical devices and pharmaceuticals can delay product approvals and market entry.
• High Costs: The high cost of advanced gynaecological treatments and devices may limit accessibility, particularly in low- and middle-income countries.
• Ethical and Cultural Barriers: In some regions, cultural beliefs and ethical concerns may hinder the adoption of certain reproductive health technologies, such as IVF and genetic testing.

The Young Researcher Awards will be presented by Meetings International at the 13th International Conference on Gynecology and Obstetrics  , which will take place in Rome, Italy, May 19-20, 2025 . The newest developments and usage of Gynecology treatments are the main topics of this Gynecology conference. Gynecology-2025 and subsequent conferences will award excellent Young Researcher Awards to participants who have made a substantial contribution to the Gynecology & Obstetrics scientific community. Through the YRF, young researchers will have the chance to meet specialists and exchange experiences at our international conferences, offering them a strong opportunity for professional development.

Advances in Reproductive Medicine, Abortion and Complications, Gynecologic Oncology, Endometriosis, Polycystic Ovary Syndrome ,Contraception and Family Planning, Female Infertility & IVF Treatment, Sexually Transmitted Diseases, Obstetric Emergencies, Technological Innovations in Obstetric Imaging will be the primary areas of attention for Gynecology in 2025. The operating committee offers a venue for trainees, post-graduate/master's students, PhD candidates, and aspiring young researchers and investigators to present their work.

Eligibility:
Faculty members, Ph.D. candidates, post-doctoral fellows, young scientists, and intelligent final-year MSc and M.Phil. candidates. Scientific industry personnel are also eligible to take part.

Criteria:

• The Young Scientist Feature provides a forum for young researchers to showcase their accomplishments and future directions, thereby advancing their careers in their fields.
• Acknowledgment as YRF Awarde Promotion on the conference website, Young Researcher Awards, and certificates.
• Link on the conference website.
• Recognition on Meetings Int. Award Page.
• Chances to coordinate with partners around the world.
• Research work can be published in the relevant journal without any publication fee.

Benefits:

• All presented abstracts will automatically be considered for the Award.
• All the presentations will be evaluated in the conference venue.
• All the awards will be selected by the judges of the award category.
• The winners of the Young Scientist Award will receive an award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

• All submissions must be in English.
• The topic must fit into the scientific sessions of the conference.
• Each participant is allowed to submit a maximum 2 papers.
• The abstract must be submitted online as per the given abstract template.
• Abstracts must be written in Times New Roman and the font size will be 12.
• The abstract must contain the title, name, affiliation, country, speaker biography, recent photograph, image, and reference

Acceptance:
To be eligible for the award, the recipient must submit the presentation for which they are being recognized, along with the author's consent, for online publication. The reward will be forfeited if the PPT and authorization are not submitted within the allotted period.

Meetings Int. is a worldwide pioneer in delivering top-notch gatherings, workshops, and symposia in every significant field of science, innovation, and medication worldwide receiving 400,000+ online visitors with 1000+ sessions which confirms the outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related to national and global affiliations, organizations, and elevated-level people, committed to having world-class meetings and occasions so it provides a big platform to show your product and advertising. The explorer’s traffic is the benchmark for advertisement, and the Gynecology Conference website is continually dragged worldwide. As specified by Google Analytics, in excess of 12,836 researchers and industrials are visiting our conference sites. Gynecology 2025 conference helps you put the spotlight on your brand by advertising with more than 9 million+ readers worldwide about 5 million+ hits every month on our site. We provide an excellent opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from powerful nations including the United States, Japan, United Kingdom, India, France, Taiwan, and Germany, etc.  Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.